Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sonova Holding AGXSWX:SOON -1.55%89 Days Sales Outstanding is 53.84 as of Mar. 2026, which is 5% below its 10-year median of 56.41. GuruFocus rates XSWX:SOON with a GF Score™ of 89/100 and a GF Value™ of CHF252.45 (Fairly Valued). The stock has 7 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Sonova Holding AG ranks better than 62.72% on this metric.
The historical rank and industry rank for Sonova Holding AG's Days Sales Outstanding or its related term are showing as below:
XSWX:SOON'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.77 Med: 56.41 Max: 64.07
Current: 55.11
During the past 13 years, Sonova Holding AG's highest Days Sales Outstanding was 64.07. The lowest was 48.77. And the median was 56.41.
XSWX:SOON's Days Sales Outstanding is ranked better than 62.72% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.21
vs XSWX:SOON: 55.11
Sonova Holding AG's Days Sales Outstanding
declined
from Mar. 2025 (57.19) to Mar. 2026 (53.84).
Sonova Holding AG (XSWX:SOON) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Sonova Holding AG Days Sales Outstanding Related Terms
Sonova Holding AG Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Sonova Holding AG's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SOON vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Sonova Holding AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonova Holding AG Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sonova Holding AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Sonova Holding AG's Days Sales Outstanding falls into.
Sonova Holding AG Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sonova Holding AG (XSWX:SOON) has a Days Sales Outstanding of 53.84 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sonova Holding AG and its competitors. This is near median its historical median of 56.41. Over the past decade, Sonova Holding AG's Days Sales Outstanding has ranged from 48.77 to 64.07. According to the industry distribution chart, Sonova Holding AG ranks #302 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 37.3%.
Is Sonova Holding AG's Days Sales Outstanding too high?
Sonova Holding AG's current Days Sales Outstanding of 53.84 is near median its 10-year median of 56.41. Over the past 10 years, this metric has ranged from a low of 48.77 to a high of 64.07. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.21. Sonova Holding AG's value of 53.84 is 17.4% below this industry median. Based on the distribution chart, Sonova Holding AG ranks #302 out of 810 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sonova Holding AG has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sonova Holding AG's Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sonova Holding AG ranks #302 out of 810 companies for Days Sales Outstanding. This puts Sonova Holding AG in the upper half of its industry. The industry median Days Sales Outstanding is 65.21. Sonova Holding AG's value of 53.84 is 17.4% below this benchmark. Historically, Sonova Holding AG's own Days Sales Outstanding has ranged from 48.77 to 64.07 over the past decade. While the company's 10-year median is 56.41 vs. the industry median of 65.21, Sonova Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.21, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonova Holding AG's current Days Sales Outstanding of 53.84 is 17.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sonova Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonova Holding AG's current Days Sales Outstanding is 53.84, which is near median its own 10-year median of 56.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonova Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Sonova Holding AG (XSWX:SOON) is currently considered Fairly Valued. The stock's GF Value™ is CHF252.45, compared to a current price of CHF236.80 — trading 6.2% below its estimated fair value. The current Days Sales Outstanding is 53.84, which is near median its 10-year median of 56.41 and 17.4% below the Medical Devices & Instruments industry median of 65.21. Sonova Holding AG's overall GF Score™ is 89/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Sonova Holding AG (XSWX:SOON), the current Days Sales Outstanding is 53.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sonova Holding AG (XSWX:SOON) Overvalued in 2026?
Based on GuruFocus' analysis, Sonova Holding AG stock appears to be undervalued.
The current stock price of CHF236.80 is trading 6.2% below its estimated GF Value™ of CHF252.45.
GuruFocus considers Sonova Holding AG to be Fairly Valued.
Key valuation signals for XSWX:SOON:
Days Sales Outstanding: 53.84 (near median its 10-year median of 56.41)
GF Value™: CHF252.45 vs. price of CHF236.80 (6.2% below fair value)
Industry Position: 17.4% below the Medical Devices & Instruments median (#302 of 810)
No single metric tells the full story. See the XSWX:SOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
89GF Score
Get the complete analysis for XSWX:SOON
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SOON has been successfully added to your 
